Clinical Trial Update: Gene Therapy for Chronic Granulomatous Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase gene therapy trial for Chronic Granulomatous Disease sponsored by NIAID was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Gene Therapy for Chronic Granulomatum Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | EARLY_Phase 1 | Status: TERMINATED